Treatment for cocaine addiction targets relapse
January 15, 2013 in Psychology & Psychiatry
An experimental drug that lowers norepinephrine levels can inhibit relapse-like behaviors in rats trained to give themselves cocaine.
(Medical Xpress)—What is the best intervention window for someone struggling with cocaine addiction? When he or she is in the middle of a drug binge, or after a period of abstinence when there is temptation to fall back into old habits?
An experimental drug called nepicastat shows promise in helping treat cocaine addiction, based on its ability to stave off relapse-like behavior in animals trained to give themselves cocaine. The National Institute on Drug Abuse is beginning a clinical trial testing nepicastat with cocaine-dependent humans this spring.
The animal results were published online this week by the journal Neuropsychopharmacology.
"The main triggers for relapse in humans are stress, the drugs themselves, or exposure to drug-associated cues, like seeing drug paraphernalia or a friend they used to do drugs with," says senior author David Weinshenker, PhD, associate professor of human genetics at Emory University School of Medicine. "We can show that nepicastat weakens animals' drive to return to cocaine-seeking behavior following a period of abstinence, when it is triggered by each of those three situations."
Nepicastat – originally developed for the treatment of heart failure – works by inhibiting the enzyme dopamine beta-hydroxylase and lowering levels of the brain chemical norepinephrine. At the junctions between nerve cells, cocaine increases the levels of both norepinephrine and its relative dopamine by blocking enzymes the brain uses to clear them away. Cocaine addiction research has generally focused more on dopamine, because it plays a large role in the feelings of pleasure produced by natural rewards such as food or sex and is "hijacked" by drugs of abuse.
Norepinephrine similarly has roles in attention, arousal, and stress, but seems particularly important for relapse behavior. Lowering norepinephrine levels does not stop animals from giving themselves a steady stream of cocaine, but it does inhibit their tendency to try to get it after a break or exposure to relapse triggers.
In the new paper, research assistant professor Jason Schroeder, PhD (first author of the paper) conducted experiments where rats are trained to press a lever to get a drug infusion. While the cocaine is being given, a light turns on. Then later after a break, the rats are exposed to the light only.
This is analogous to a human addict, during a period of abstinence, coming to a place where they used to take drugs or meeting a friend with whom they did drugs, Weinshenker says. Nepicastat reduces the number of times a rat will push the lever in an attempt to get cocaine. It also works when this relapse-like behavior is brought on by a small dose of cocaine or yohimbine, a drug that induces anxiety and stress responses in humans.
In a situation where a rat has to press a lever an increasing number of times to get a drug infusion, nepicastat also reduces how hard the rat is willing to "work" to get the cocaine. A rat might normally push a lever up to 75 times to get one infusion of cocaine – but nepicastat will cut that number to 45. However, nepicastat does not prevent rats from working hard to obtain other rewards such as food or sugar.
Recent small-scale studies in humans suggest that nepicastat may make cocaine less enjoyable. In addition, Weinshenker's laboratory has also recently found that nepicastat makes animals more sensitive to aversive behaviors induced by cocaine, such as repetitive movements that are thought to model psychosis. In fact, humans with low levels of dopamine beta-hydroxylase, the enzyme that is inhibited by nepicastat, are more susceptible to cocaine-induced paranoia.
Weinshenker is co-inventor on a patent on the use of dopamine beta-hydroxylase inhibitors for the treatment of cocaine dependence. This has been reviewed by Emory in accordance with its conflict of interest policies.
More information: Schroeder, J., Epps, S., Grice, T. and Weinshenker, D. The Selective Dopamine β-Hydroxylase Inhibitor Nepicastat Attenuates Multiple Aspects of Cocaine-Seeking Behavior. Neuropsychopharm. (2013) doi: 10.1038/npp.2012.267
Journal reference:
Neuropsychopharmacology
Provided by
Emory University
-
Experimental treatments for cocaine addiction may prevent relapse
Aug 26, 2010 |
not rated yet |
0
-
Research indicates that a common heart drug may reduce cocaine cravings
Feb 27, 2008 |
not rated yet |
0
-
Injections of licorice ingredient show promise as treatment for cocaine addiction
Feb 20, 2009 |
not rated yet |
0
-
Cocaine addiction linked to voluntary drug use and cellular memory
Jul 30, 2008 |
not rated yet |
0
-
Brain mechanism linked to relapse after cocaine withdrawal
Sep 08, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Storm chasers: born to be wild?
(HealthDay)—We've all seen them: the surfers who race to the beach when a hurricane hits, the guy who decides to ride out the storm in his overmatched boat, the tornado chasers who fearlessly steer their ...
Psychology & Psychiatry
May 24, 2013 |
not rated yet |
0
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Psychology & Psychiatry
May 24, 2013 |
4 / 5 (4) |
4
|
Are there atheists in foxholes? Study says they're the minority
Ernie Pyle – an iconic war correspondent in World War II – reportedly said "There are no atheists in foxholes." A new joint study between two brothers at Cornell and Virginia Wesleyan found that only ...
Psychology & Psychiatry
May 24, 2013 |
2.5 / 5 (4) |
2
Breathing exercises help veterans find peace after war, scholar says
(Medical Xpress)—Research by Stanford scholar Emma Seppala at the Center for Compassion and Altruism Research and Education found that post-traumatic stress disorder decreased in veterans who participated ...
Psychology & Psychiatry
May 24, 2013 |
5 / 5 (1) |
1
Depression raises diabetics' risk of severe low blood sugar episodes
(Medical Xpress)—Patients with diabetes who are depressed are much more likely to develop episodes of dangerously low blood sugars, or hypoglycemia, than are those who are not depressed, a new study has ...
Psychology & Psychiatry
May 24, 2013 |
not rated yet |
0
|
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.